Novo Nordisk (NVO)
(Delayed Data from NYSE)
$128.40 USD
+0.35 (0.27%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $128.50 +0.10 (0.08%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: -- |
3/2024 | $0.79 | -0.64% |
Earnings Summary
For their last quarter, Novo Nordisk (NVO) reported earnings of $0.71 per share, beating the Zacks Consensus Estimate of $0.66 per share. This reflects a positive earnings surprise of 7.58%. Look out for NVO's next earnings release expected on May 02, 2024. For the next earning release, we expect the company to report earnings of $0.79 per share, reflecting a year-over-year increase of 23.44%.
Earnings History
Price & Consensus
Zacks News for NVO
Pharma Stock Roundup: ABBV & NVO's New M&As, FDA Nod to JNJ & MRK PAH Drugs
NVO: What are Zacks experts saying now?
Zacks Private Portfolio Services